NovoCure (NASDAQ:NVCR) Earns Buy Rating from Analysts at HC Wainwright
Equities research analysts at HC Wainwright started coverage on shares of NovoCure (NASDAQ:NVCR – Get Rating) in a research note issued to investors on Monday, The Fly reports. The brokerage set a “buy” rating on the medical equipment provider’s stock. NVCR has been the topic of several other research reports. Truist Financial upgraded shares of […]